https://www.eurekalert.org/pub_releases/2021-01/nrco-cwl011121.php Skip to main content [SEARCH ARCHIVE ] Advanced Search EurekAlert! Science NewsA service of the American Association for the Advancement of Science EurekAlert! Science NewsA service of the American Association for the Advancement of Science * Home * COVID-19 * News Releases + o Latest News Releases o News By Subject # Agriculture # Archaeology # Atmospheric Science # Biology # Business & Economics # Chemistry & Physics # Earth Science # Education # Mathematics # Medicine & Health # Policy & Ethics # Social & Behavioral # Space & Planetary # Tech & Engineering o Science Business Announcements o Grants, Awards, Books o Languages # Auf Deutsch # En Espanol # En Francais # Em Portugues # Ri Ben Yu # Zhong Wen o Portals # Climate Change # Cancer Research # Marine Science o E-mail Newsletter + o Latest News Releases o o Science Business Announcements o Grants o Awards o Books o o E-mail Newsletter o RSS Feeds o Agriculture o Archaeology o Atmospheric Science o Biology o Business & Economics o Chemistry & Physics o Earth Science o Education o Mathematics o Medicine & Health o Policy & Ethics o Social & Behavior o Space & Planetary o Tech & Engineering o Auf Deutsch o En Espanol o En Francais o Em Portugues o Ri Ben Yu o o Zhong Wen * Multimedia + o All multimedia o Images o Video o Audio o Search multimedia + o All Multimedia o o Search Multimedia [browse-ima] Images [browse-vid] Video [browse-aud] Audio * Meetings + o Meeting Announcements o Meetings Calendar o Featured Newsrooms: AHA Scientific Sessions 2020 13 - 17 November 2020 Virtual + o Meeting Announcements o Meetings Calendar o o o o o Featured Newsrooms AHA Scientific Sessions 2020 * Portals + o Hello World o Foo Bar o Dropdown Menu # Hello World # Foo Bar o Another Link o The Last Item + Climate Change Portal Climate ChangeThe latest insights into the changing climate More Cancer Research Portal Cancer ResearchNew findings in cancer treatment and prevention More Marine Science Portal Marine ScienceIn-depth investigations on all things marine science More Science Agencies o US Department of Energy o US National Institutes of Health o US National Science Foundation * About + o About EurekAlert! o For Reporters o For PIOs o FAQ o Subscribe / Sponsor o Contact EurekAlert! o News Release Eligibility Guidelines + o About EurekAlert! o FAQ o Subscribe / Sponsor o o o Contact EurekAlert! o News Release Eligibility Guidelines For Reporters EurekAlert! provides eligible reporters with free access to embargoed and breaking news releases. Eligibility Guidelines For PIOS EurekAlert! offers eligible public information officers paid access to a reliable news release distribution service. Eligibility Guidelines AAAS Logo EurekAlert! is a service of the American Association for the Advancement of Science. * Login * Register News Release 14-Jan-2021 Chemotherapy with light; only one injection required Chemotherapy with only one injection, repeated phototherapy, and no side effects. Development of a cancer-targeted single component supramolecular peptide phototherapeutic agent National Research Council of Science & Technology Research News Share Print E-Mail IMAGE IMAGE: A schematic diagram of the application of cancer-targeted supermolecular peptide phototherapy drugs to animal experiments developed by KIST researchers. A single supermolecular peptide phototherapy injection and repeated phototherapy were used... view more Credit: Korea Institute of Science and Technology(KIST) Researchers in South Korea have developed a phototherapy technology that can significantly increase efficiency while reducing the pain of chemotherapy and minimizing side effects after treatment. The President of Korea Institute of Science and Technology (KIST), Seok-Jin Yoon announced that a research team led by Dr. Sehoon Kim at the Theragnosis Research Center (KU-KIST Graduate School of Converging Science and Technology) has developed a cancer-targeted phototherapeutic agent that promises complete elimination of cancer cells without side effects. It involves only one injection and repeated phototherapy. This development was made through joint research with Professor Dong June Ahn of Korea University and Professor Yoon-Sik Lee of Seoul National University. Phototherapy technology, a cancer treatment modality that uses light, injects a photosensitizer that destroys cancer cells in response to a laser, which accumulates in only cancerous tissues. Further, it shoots light to selectively destroy the cancer cells. It has far fewer side effects than radiation therapy or general chemotherapy (that inevitably damage the tissues surrounding the cancer cells), allowing repeated treatment. Since the effect of the conventional photosensitizers only lasts for one session, photosensitizers have to be administered each time the treatment procedure is repeated. Moreover, the residual photosensitizer after treatment accumulates in the skin or eyes causing side effects due to light; thus, it is recommended to isolate the patient from sunlight and indoor lighting for some time after treatment. Overall, the patients receiving phototreatment have had to suffer from the pain of the repeated injection and the inconvenience of isolation in the dark each time. Recently, photosensitizers with phototherapeutic effects that get activated only in cancer tissues have been developed; however, they are still toxic and have to be injected for every repeated session of treatment. Dr. Sehoon Kim and his team at KIST used peptides that selectively target cancer tissues and assemble themselves in a specific order to resolve the problems associated with the phototherapy technology. The research team developed a peptide-based photosensitizer that activates phototherapeutic effects only in cancer tissues by using the internalizing RGD peptide (iRGD) that can selectively penetrate and target cancer tissues, and by proper design for the modulation of its reaction to light. When this newly developed photosensitizer is injected into a living body, it is activated by the body temperature and aggregates into a supramolecular arrangement designed by the research team, to be stored around the tumor. The subsequent phototherapy can destroy only cancer cells without affecting surrounding normal cells. The phototherapeutic agent developed by the researchers was injected into a mouse model implanted with a tumor, and the photosensitizer was stored around the tumor and was continuously released for a long time (2 to 4 weeks), demonstrating the ability of selectively targeting the tumor with just a single injection around the cancerous tissues. Moreover, no toxicity was found to destroy the surrounding tissues and major organs, even with repeated exposure to light. The cancerous tissues were completely removed through repeated procedures. "We developed a cancer-targeting peptide phototherapeutic agent that forms a depot through supramolecular self-assembly without additional excipients when injected in vivo," said KIST Center Director Sehoon Kim. "The developed phototherapeutic agent is expected to be useful in future phototherapy as it allows long-term repeated phototherapy without toxicity after only one injection around the cancer until the complete removal of the cancer, and has a simple formulation with a single component," he added. ### This study was carried out with a grant from the Ministry of Science and ICT (MSIT), as part of the Institutional R&D Program of KIST. The results of this study were published in the latest issue of "ACS Nano " (IF: 14.588, the top 5.25% in JCR), an international journal in the field of nanotechnology. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system. Share Print E-Mail Media Contact Do-Hyun Kim ddd@kist.re.kr 82-295-86344 https://www.nst.re.kr/nst_en/ --------------------------------------------------------------------- --------------------------------------------------------------------- More on this News Release Chemotherapy with light; only one injection required National Research Council of Science & Technology Journal ACS Nano Funder Ministry of Science and ICT --------------------------------------------------------------------- Keywords * BIOLOGY * MEDICINE/HEALTH * TECHNOLOGY/ENGINEERING/COMPUTER SCIENCE Multimedia A schematic diagram of the application of cancer-targeted supermolecular peptide phototherapy drugs A schematic diagram of the application of cancer-targeted supermolecular peptide phototherapy drugs (IMAGE) view more Se-hoon Kim, Korea Institute of Science and Technology Se-hoon Kim, Korea Institute of Science and Technology (IMAGE) view more Related Journal Article http://dx.doi.org/10.1021/acsnano.0c06881 --------------------------------------------------------------------- --------------------------------------------------------------------- More in Biology * Regulating the ribosomal RNA production line Penn State * NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests American Society for Microbiology * From fins to limbs Harvard University, Department of Organismic and Evolutionary Biology * Rediscovery of the 'extinct' Pinatubo volcano mouse Field Museum View all in Biology --------------------------------------------------------------------- --------------------------------------------------------------------- Trending News Releases * Astronomers discover first cloudless, Jupiter-like planet Harvard-Smithsonian Center for Astrophysics * Combined river flows could send up to 3 billion microplastics a day into the Bay of Bengal University of Plymouth * Patients in cancer remission at high risk for severe COVID-19 illness University of Pennsylvania School of Medicine * Antibiotic resistance may spread even more easily than expected Chalmers University of Technology View all latest news releases --------------------------------------------------------------------- --------------------------------------------------------------------- EurekAlert! The Global Source for Science News AAAS - American Association for the Advancement of Science Copyright (c) 2021 by the American Association for the Advancement of Science (AAAS) * Latest News Releases RSS Feed * All EurekAlert! RSS Feeds * @EurekAlert * facebook.com/EurekAlert --------------------------------------------------------------------- * Help / FAQ * Disclaimer * Privacy Policy * Terms & Conditions * Contact EurekAlert! --------------------------------------------------------------------- Copyright (c) 2021 by the American Association for the Advancement of Science (AAAS)